Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities

Cancer Research

Volumn 57, Issue 6, 1997, Pages 1199-1205

  Tan, Ming ^a   Yao, Jun ^a   Yu, Dihua ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P185; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CELL TRANSFORMATION; FEMALE; GENE EXPRESSION REGULATION; METASTASIS POTENTIAL; MOUSE; NONHUMAN; ONCOGENE C ERB; PRIORITY JOURNAL; PROMOTER REGION; TUMOR PROMOTION;

ANIMALS; BASEMENT MEMBRANE; BREAST NEOPLASMS; CELL ADHESION; CELL MOVEMENT; COLLAGENASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-2; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED ICR; MICE, SCID; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; RECEPTOR, ERBB-2; TRANSFECTION; TUMOR STEM CELL ASSAY;

EID: 0030968290     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Liotta, L. A., Steeg, P. S., and Stetler-Stevenson, W. G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64: 327-336, 1991.
2. Bargmann, C. I., Hung, M-C., and Weinberg, R. A. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature (Lond.), 319: 226-230, 1986.
3. Yamamoto, T., Ikawa, S., Akiyama, T., Semba, K., Nomura, N., Miyajima, N., Saito, T., and Toyoshima, K. Similarity of protein encoded by the human c-erbft-2 gene to epidermal growth factor. Nature (Lond.), 319: 230-234, 1986.
4. Akiyama, T., Sudo, C., Ogawara, H., Toyoshima, K., and Yamamoto, T. The product of the human c-erbE-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science (Washington, DC), 232: 1644-1646, 1986.
5. Coussens, L., Yang-Feng, T. L., Liao, Y-C., Chen, E., Gray, A., McGrath, J., Seeburg, P. H., Libermann, T. A., Schlessinger, J., Francke, U., Levinson, A., and Ullrich, A. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science (Washington. DC), 230: 1132-1139, 1985.
6. Stem, D. F., Heffernan, P. A., and Weinberg, R. A. p 185, a product of the neu proto-oncogene, is a receptor-like protein associated with tyrosine kinase activity. Mol. Cell. Biol., 6: 1729-1740, 1986.
7. Slamon, D. J., Godolphin. W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., and McGuire, W. L. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (Washington, DC), 244: 707-712, 1989.
8. Lacroix, H., Iglehart, J. D., Skinner, M. A., and Kraus, M. H. Overexpression of erbB-2 or EGF-receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastasis. Oncogene, 4: 145-151, 1989.
9. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, W. L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (Washington, DC), 235: 177-182, 1987.
10. Tauchi, K., Hori, S., Itoh, H., Osamura, R. Y., Tokuda, Y., and Tajima, T. Immunohistochemical studies on oncogene products (c-erbB-2, EGFR, c-myc) and estrogen receptor in benign and malignant breast lesions: with special reference to their prognostic significance in carcinoma. Virchows Arch. A Pathol. Anat. Histopathol., 416: 65-73, 1989.
11. Yusa, K., Sugimoto, Y., Yamori, T., Yamamoto, T., Toyoshima, K., and Tsuruo, T. Low metastatic potential of clone from murine colon adenocarcinoma 26 increased by transfection of activated c-erbB-2 gene. J. Natl. Cancer Inst., 82: 1633-1636, 1990.
12. Padhy, L. C., Shih, C., Cowing, D., Finkelstein, R., and Weinberg, R. A. Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas. Cell, 28: 865-871, 1982.
13. Yu, D., and Hung, M. C. Expression of activated rat neu oncogene is sufficient to induce experimental metastasis in 3T3 cells. Oncogene, 6: 1991-1996, 1991.
14. Suda, Y., Aizawa, S., Furuta, Y., Yagi, T., Ikawa, Y., Saitoh, K., Yamada, Y., Toyoshima, K., and Yamamoto, T. Induction of a variety of tumors by c-erb32 and clonal nature of lymphomas even with the mutated gene (Val659-GIu659). EMBO J., 9: 181-190, 1990.
15. Muller, W. J., Sinn, E., Pattengale, P. K., Wallace, R., and Leder, P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell, 54: 105-115, 1988.
16. Bouchard, L., Lamarre, L., Tremblay, P. J., and Jolicoeur, P. Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene. Cell, 57: 931-936, 1989.
17. Guy, C. T., Webster, M. A., Schaller, M., Parsons, T. J., Cardiff, R. D., and Muller, W. J. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl. Acad. Sci. USA, 89: 10578-10582, 1992.
18. Saya, H., Ara, S., Lee, P. S., Ro, J., and Hung, M-C. Direct sequencing analysis of transmembrane region of human neu gene by polymerase chain reaction. Mol. Carcinog., 3: 198-201, 1990.
19. Lemoine, N. R., Staddon, S., Dickson, C., Barnes, D. M., and Gullick, W. J. Absence of activating transmembrane mutations in the c-erbB-2 proto-oncogene in human breast cancer. Oncogene, 5: 237-239, 1990.
20. Ali, I. U., Campbell, G., Lidereau, R., and Callahan, R. Lack of evidence for the prognostic significance of c-erbE-2 amplification in human breast carcinoma. Oncogene Res., 3: 139-146, 1988.
21. Cailleau, R., Young, R., Olive, M., and Reeves, W. Breast tumor cell lines from pleural effusions. J. Natl. Cancer Inst., 53: 661-674, 1974.
22. Yu, D., Liu, B-, Tan, M., Li, J., Wang, S-S., and Hung, M-C. Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1independent mechanisms. Oncogene, 13: 1359-1365, 1996.
23. Yu, D., Hamada, J-I., Zhang, H., Nicolson, G. L., and Hung, M-C. Mechanisms of neu oncogene induced metastasis and abrogation of metastatic properties by the adenovirus 5 E1A gene products. Oncogene, 7: 2263-2270, 1992.
24. Wexler, H. Accurate identification of experimental pulmonary metastasis. J. Natl. Cancer Inst., 36: 641-645, 1966.
25. Albini, A., Iwamoto, Y., Kleinman, H. K., Martin, G. R., Aaronson, S. A., Kozlowski, J. M., and McEwan, R. N. A rapid m vitro assay for quantitating the invasive potential of tumor cells. Cancer Res., 47: 3239-3245, 1987.
26. Yu, D., Wang, S-S., Dulski, K. M., Tsai, C-M., Nicolson, G. L., and Hung, M-C. c-erbE-2/neu overexpression enhanced metastatic potential in human lung cancer cells. Cancer Res., 54: 3260-3266, 1994.
27. Mensing, H., Pontz, B. F., Muller, P. K., and Gauss-Muller, V. A study on fibroblast chemotaxis using fibronectin and conditioned medium as chemoattractants. Eur. J. Cell Biol., 29: 268-273, 1983.
28. Zhang, R. D., Fidler, I. J., and Price, J. E. Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis. Invasion Metastasis, 11: 204-215, 1991.
29. Kraus, M. H., Popescu, N. C., Amsbaugh, S. C., and King, C. R. Overexpression of the EGF receptor-related proto-oncogene erb&-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J., 6: 605-610, 1987.
30. Repesh, L. A. A new in vitro assay for quantitating tumor cell invasion. Invasion Metastasis, 9: 192-208, 1989.
31. Nicolson, G. L. Metastatic tumor cell interaction with endothelium, basement membrane and tissue. Curr. Opin. Cell Biol., 1: 1009-1019, 1989.
32. Nicolson, G. L. Molecular mechanisms of cancer metastasis: tumor and host properties and the role of oncogenes and suppressor genes. Curr. Opin. Oncol., 3: 75-92, 1991.
33. Tressler, R. J., Belloni, P. N., and Nicolson, G. L. Correlation of inhibition of adhesion of large cell lymphoma and hepatic sinusoidal endothelial cells by RGDcontaining peptide polymers with metastatic potential: role of integrin-dependent and -independent adhesion mechanisms. Cancer Commun., 1: 55-63, 1989.
34. Bonfil, R., Vinyals, A., Bustuoabad, O., Liorens, A., and Benavides, F. Stimulation of angiogenesis as an explanation of Matrige 1-enhanced tumorigenicity. Int. J. Cancer, 58: 233-239, 1994.
35. Leone, A., Flatow, U., King, C. R., Sandeen, M. A., Margulies, L M. K., Liotta, L. A., and Steeg, P. S. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell, 65: 25-35, 1991.
36. Yu, D., Wolf, J. K., Scanlon, M., Price, J. E., and Hung, M-C. Enhanced c-erbE-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A. Cancer Res., 53: 891-898, 1993.
37. Stetler-Stevenson, W., Liotta, L., and Kleiner, D. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J., 7: 1434-1441, 1993.
38. Liotta, L., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C., and Shafie, S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature (Lond.), 28: 67-68, 1980.
39. Nakajima, M., Welch, D., Belloni, P., and Nicolson, G. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res., 47: 4869-4876, 1987.
40. Murphy, G., Reynolds, J., and Hembry, R. M. Metalloproteinases and cancer invasion and metastasis. Int. J. Cancer, 44: 757-760, 1989.
41. Poulsom, R., Hanby, A., Pignatelli, M., and Jeffery, R. Expression of gelatinase A and TIMP-2 niRNAs in desmoplastic fibroblasts in both mammary carcinomas and basal cell carcinomas of the skin. J. Clin. Pathol., 46: 429-436, 1993.
42. Okada, Y. T., Shimizu, H., Tomita, K., Nakanishi, I., Sato, H., Seiki, M., Yamashita, K., and Hayakawa, T. Induction and stimulation of 92 kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor a. Biochem. Biophys. Res. Commun., 171: 610-617, 1990.
43. Lauricella-Lefebvre, M. A., Castronovo, V., Sato, H. Seiki, M. French, D. L., and Merville, M. P. Stimulation of the 92 kD type IV collagenase promoter and enzyme expression in human melanoma cells. Invasion Metastasis, 13: 289-300, 1993.
44. Sato, H., Seiki, M. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene, 8: 395-405, 1993.
45. Sato, H. K., and Seiki, M. v-Src activates the expression of 92 kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines. J. Biol. Chem., 265: 23460-23468, 1993.
46. Gum, R., Lengyel, E., Juarez, J., Chen, J. H., Sato, H., Seiki, M., and Boyd, D. Stimulation of 92 kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J. Biol. Chem., 277: 10672-10680, 1996.
47. Segatto, O. P., Giuli, G., Digiesi, G., Di Fiore, P. P., McGIade, J., Pawson, T., and Pelicci, P. G. She products are substrates of erbB-2 kinase. Oncogene, 8: 2105-2112, 1993.
48. Xie, Y., Li, K., and Hung, M-C. Tyrosine phosphorylation of She proteins and formation of Shc/Grb2 complex correlate to the transformation of NIH3T3 cells mediated by the point-mutation activated neu. Oncogene, 10: 2409-2413. 1995.
49. Hung, M. The neu proto-oncogene and breast cancer. Cancer Bull., 40: 300-303, 1988.